0001131096-18-000084.txt : 20180305
0001131096-18-000084.hdr.sgml : 20180305
20180305174918
ACCESSION NUMBER: 0001131096-18-000084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180301
FILED AS OF DATE: 20180305
DATE AS OF CHANGE: 20180305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Brien Timothy John
CENTRAL INDEX KEY: 0001662445
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33689
FILM NUMBER: 18667717
MAIL ADDRESS:
STREET 1: C/O ATHENAHEALTH, INC.
STREET 2: 311 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 01880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATHENAHEALTH INC
CENTRAL INDEX KEY: 0001131096
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 043387530
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 311 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-402-1000
MAIL ADDRESS:
STREET 1: 311 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
wf-form4_152029014330291.xml
FORM 4
X0306
4
2018-03-01
0
0001131096
ATHENAHEALTH INC
ATHN
0001662445
O'Brien Timothy John
C/O ATHENAHEALTH, INC.
311 ARSENAL ST.
WATERTOWN
MA
02472
0
1
0
0
SVP, Chief Marketing Officer
Common Stock
2018-03-01
4
A
0
285
0
A
11320
D
Common Stock
2018-03-01
4
F
0
84
139.74
D
11236
D
Common Stock
2018-03-01
4
A
0
745
0
A
11981
D
Common Stock
2018-03-01
4
F
0
220
139.74
D
11761
D
Common Stock
2018-03-01
4
F
0
66
139.74
D
11695
D
Common Stock
2018-03-01
4
F
0
148
139.74
D
11547
D
Common Stock
2018-03-01
4
F
0
63
139.74
D
11484
D
Common Stock
2018-03-01
4
F
0
921
139.74
D
10563
D
Common Stock
2018-03-01
4
A
0
1500
0
A
12063
D
Common Stock
2018-03-02
4
S
0
164
136
D
11899
D
Common Stock
2018-03-02
4
S
0
1100
136.92
D
10799
D
Common Stock
2018-03-02
4
S
0
1800
137.60
D
8999
D
Stock Option (Right to Buy)
137.49
2018-03-01
4
A
0
3690
0
A
2019-03-01
2028-03-01
Common Stock
3690.0
3690
D
On March 1, 2016, the Reporting Person was granted a Performance Stock Unit ("PSU") award of 2,719 PSUs. The PSUs convert into common stock on a one-for-one basis, and vest in three equal annual installments beginning on March 1, 2017 based on the Issuer's satisfaction of certain performance criteria for the fiscal years ending December 31, 2016, 2017 and 2018. On February 6, 2018, the Compensation Committee of the Board of Directors of the Issuer certified that certain performance criteria for 2017 was met, resulting in vesting of PSUs as to 285 shares on March 1, 2018.
On March 1, 2017, the Reporting Person was granted an award of 6,686 PSUs. The PSUs convert into common stock on a one-for-one basis, and vest in three equal annual installments beginning on March 1, 2018 based on the Issuer's satisfaction of certain performance criteria for the fiscal years ending December 31, 2017, 2018 and 2019. On February 6, 2018, the Compensation Committee of the Board of Directors of the Issuer certified that certain performance criteria for 2017 was met, resulting in vesting of PSUs as to 745 shares on March 1, 2018.
Represents a restricted stock unit ("RSU") award granted under the Issuer's 2007 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The award is subject to time-based vesting and vests in three equal annual installments beginning on March 1, 2019. The RSUs will be settled only in stock.
The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 13, 2017, in accordance with Rule 10b5-1.
Represents a weighted average price. These shares were purchased by the Reporting Person in multiple transactions at prices ranging from $136.46 to $137.19, inclusive.
Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $137.27 to $138.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (5) and (6).
Includes 6,974 units of common stock that were granted pursuant to RSU awards under the athenahealth, Inc. 2007 Stock Option and Incentive Plan, as amended and restated. The RSUs are subject to time-based vesting and will be settled only in stock.
The option award vests in three equal annual installments beginning on March 1, 2019.
/s/ Dan Haley, Attorney-in-Fact
2018-03-05